Price
$1.7
Increased by +14.86%
Dollar Volume
168.76 K
ADR%
7.77
Earnings Report Date (estimate)
Feb 8, 23 (-0.29)
Market Cap.
21.94 M
Shares Float
12.73 M
Shares Outstanding
12.91 M
Beta
0.55
Price / Earnings
-0.89
BPR
97.93
20D Range
1.31 1.75
50D Range
1.20 1.92
200D Range
0.62 7.35
  • Quarterly Earnings
  • Annual Earnings
Reported Date EPSChange YoY EstimateSurprise
Dec 14, 22 -0.01
Increased by +98.33%
-0.26
Increased by +96.15%
Aug 11, 22 -0.13
Increased by +71.74%
-0.35
Increased by +62.86%
May 12, 22 -0.23
Decreased by -9.52%
-0.33
Increased by +30.30%
Feb 10, 22 -0.63
Increased by +28.41%
-0.27
Decreased by -133.33%
Dec 9, 21 -0.60
Increased by +23.08%
-0.37
Decreased by -62.16%
Aug 12, 21 -0.46
Increased by +36.11%
-0.26
Decreased by -76.92%
May 13, 21 -0.21
Increased by +73.42%
-0.21
Feb 11, 21 -0.88
Increased by +21.43%
-0.54
Decreased by -62.96%
  • Quarterly Financials
  • Annual Financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 22 3.56 M
Increased by +17.09%
-774.18 K
Increased by +82.84%
Decreased by -21.75%
Increased by +85.34%
Jun 30, 22 4.30 M
Increased by +152.68%
-1.12 M
Increased by +67.40%
Decreased by -26.17%
Increased by +87.10%
Mar 31, 22 6.15 M
Increased by +130.10%
-1.76 M
Decreased by -15.95%
Decreased by -28.61%
Increased by +49.61%
Dec 31, 21 4.17 M
Increased by +157.76%
-4.72 M
Increased by +1.84%
Decreased by -113.33%
Increased by +61.92%
Sep 30, 21 3.04 M
Increased by +868.10%
-4.51 M
Decreased by -9.41%
Decreased by -148.40%
Increased by +88.70%
Jun 30, 21 1.70 M
Increased by +294.03%
-3.45 M
Decreased by -4.85%
Decreased by -202.84%
Increased by +73.39%
Mar 31, 21 2.67 M
Increased by +383.56%
-1.52 M
Increased by +48.62%
Decreased by -56.78%
Increased by +89.37%
Dec 31, 20 1.62 M
Increased by +155.11%
-4.81 M
Decreased by -80.63%
Decreased by -297.60%
Increased by +29.20%
  • Top 20 ETF Stock Exposure
  • Top 20 Institutional Holders
  • Top 20 Mutual Fund Holders
Rank ETF Shares Market Value Weight % in ETF
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. The company operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR)-based MDx testing services for the Monkeypox virus; and MDx test kits and related supplies, as well as validates pharmacogenetics (PGx) testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, leather, pharmaceuticals, nutraceuticals, and other products; SigNify IF portable DNA readers and SigNify consumable reagent test kits, which offers a front-line solution for supply chain integrity backed with forensic-level molecular tag authentication; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.